bisbenzimidazole has been researched along with Idiopathic Parkinson Disease in 2 studies
Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bossolasco, P | 1 |
| Cova, L | 1 |
| Levandis, G | 1 |
| Diana, V | 1 |
| Cerri, S | 1 |
| Lambertenghi Deliliers, G | 1 |
| Polli, E | 1 |
| Silani, V | 1 |
| Blandini, F | 1 |
| Armentero, MT | 1 |
| Li, J | 1 |
| Fan, Y | 1 |
| Zhang, YN | 1 |
| Sun, DJ | 1 |
| Fu, SB | 1 |
| Ma, L | 1 |
| Jiang, LH | 1 |
| Cui, C | 1 |
| Ding, HF | 1 |
| Yang, J | 1 |
2 other studies available for bisbenzimidazole and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Noninvasive near-infrared live imaging of human adult mesenchymal stem cells transplanted in a rodent model of Parkinson's disease.
Topics: Administration, Intranasal; Analysis of Variance; Animals; Bisbenzimidazole; Cell Proliferation; Cel | 2012 |
The Raf-1 inhibitor GW5074 and the ERK1/2 pathway inhibitor U0126 ameliorate PC12 cells apoptosis induced by 6-hydroxydopamine.
Topics: Apoptosis; Bisbenzimidazole; Blotting, Western; Butadienes; Cell Survival; Enzyme Inhibitors; Flow C | 2012 |